Announcements


15.Apr.25On May 13, 2025, the U.S. Patent and Trademark Office (USPTO) will expedite Issue Dates for...

08.Apr.25Ladas & Parry attorney John Richards will serve as a moderator and a speaker during the 32nd...

26.Mar.25On April 3rd Ladas & Parry partner D. Prahl will be a panelist (Panel 3) during the MEFLA x...

25.Mar.25An article by Dennis Prahl, Ravindra Persaud and Olivia Dinkins titled: “TTAB Sustains...

View all Announcements »


ladas-brochure-download

  • In re Peterson involved an appeal from the USPTO Board of Appeals with respect to the patentability of the claims of a pending US patent...

    Details Share b
  • This is a complex case involving a non-naturally occurring erythropoietin-glycoprotein product having a defined in vivo biological activity and having glycosylation which differs from that of human urinary...

    Details Share b
  • This was a Paragraph IV certification case filed after Novopharm filed an ANDA to market a generic form of fenofibrate prior to expiration of the relevant...

    Details Share b
  • The invention related to the isolation of the virus that caused “Mystery swine disease” (a.k.a Porcine Reproductive Respiratory Syndrome – PRRS). The claim was directed to growing and isolating a particular virus. The alleged infringement...

    Details Share b